semaglutide non responder

semaglutide non responder

Semaglutide Is Broken For 3‑In‑10?

Approximately 30% of patients prescribed semaglutide or tirzepatide fail to lose at least 5% of body weight, showing a sizable non-responder population. These real-world outcomes contrast with the 15-20% weight loss reported in pivotal trials, prompting clinicians to ask why some patients simply do not respond. Medical Disclaimer: This article